세계의 빌리루빈 혈액 검사 시장 :검사 유형, 최종 사용자, 용도, 제품별 예측(2025-2030년)

The Bilirubin Blood Test Market was valued at USD 1.09 billion in 2023, expected to reach USD 1.20 billion in 2024, and is projected to grow at a CAGR of 10.73%, to USD 2.23 billion by 2030.

The bilirubin blood test market, encompassing diagnostic procedures to measure bilirubin levels in the blood, is pivotal in diagnosing and monitoring liver diseases, hemolytic anemia, and neonatal jaundice. The necessity of these tests is underscored by the increasing prevalence of liver disorders, driven by lifestyle changes, alcohol consumption, and viral infections like hepatitis. End-use applications predominantly include hospitals, diagnostic laboratories, and outpatient care centers, each requiring precise and timely diagnostic services to aid in patient management. Market growth is influenced by the rising demand for advanced diagnostic techniques, heightened awareness about liver health, and the increasing geriatric population, prone to liver diseases. Additionally, technological innovations such as point-of-care testing and the development of non-invasive diagnostic tools present substantial growth opportunities. Companies investing in R&D for more accurate and accessible testing methods stand to capitalize on the burgeoning demand. However, the market faces challenges like stringent regulatory requirements and the high costs associated with advanced testing technologies, which may constrain smaller laboratories and emerging economies. In terms of innovation, there is promising potential in exploring artificial intelligence-driven diagnostic tools to enhance test accuracy and patient outcomes. Additionally, research into more seamless integration of bilirubin testing in home-based settings could open new market segments. Despite these opportunities, the market is somewhat constrained by the lack of awareness and inadequate healthcare infrastructure in developing regions, highlighting a need for educational campaigns and infrastructure investments. Overall, focusing on enhancing test accessibility, accuracy, and affordability through technological advancements and strategic partnerships would be pivotal for market players to exploit this niche while overcoming existing limitations. As the market evolves, it presents a fertile ground for innovation, particularly in personalized medicine and mobile health technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bilirubin Blood Test Market

The Bilirubin Blood Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
  • Surge in point-of-care testing driving convenience and faster results for bilirubin levels
  • Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
  • Government health policies and funding favoring advancements and accessibility of bilirubin testing
• Market Restraints
  • Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
  • Long approval process for new bilirubin test methods and technologies by regulatory bodies
• Market Opportunities
  • Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
  • Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
  • Partnerships between hospitals and research institutions for innovative bilirubin test solutions
• Market Challenges
  • Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
  • Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies

Porter's Five Forces: A Strategic Tool for Navigating the Bilirubin Blood Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bilirubin Blood Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bilirubin Blood Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bilirubin Blood Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bilirubin Blood Test Market

A detailed market share analysis in the Bilirubin Blood Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bilirubin Blood Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bilirubin Blood Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bilirubin Blood Test Market

A strategic analysis of the Bilirubin Blood Test Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bilirubin Blood Test Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, DiaSorin, Fujifilm Holdings Corporation, GE Healthcare, Horiba Medical, Mindray, PerkinElmer, Philips Healthcare, Quidel Corporation, Randox Laboratories, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Tosoh Bioscience, and Trinity Biotech.

Market Segmentation & Coverage

This research report categorizes the Bilirubin Blood Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Test Type, market is studied across Delta Bilirubin Test, Direct Bilirubin (DBIL) Test, Indirect Bilirubin (IBIL) Test, and Total Serum Bilirubin (TSB) Test. The Total Serum Bilirubin (TSB) Test is further studied across Direct (Conjugated) Bilirubin Test and Indirect (Unconjugated) Bilirubin Test.
• Based on End User, market is studied across Ambulatory Surgical Centers (ASCs), Diagnostic Laboratories, Home Care Settings, Hospitals, and Research Institutes.
• Based on Application, market is studied across Bile Duct Obstruction, Drug-Related Toxicity, Hemolytic Anemia, Liver Diseases, and Newborn Jaundice.
• Based on Product, market is studied across Instruments and Reagents & Kits.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
    • 5.1.1.2. Surge in point-of-care testing driving convenience and faster results for bilirubin levels
    • 5.1.1.3. Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
    • 5.1.1.4. Government health policies and funding favoring advancements and accessibility of bilirubin testing
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
    • 5.1.2.2. Long approval process for new bilirubin test methods and technologies by regulatory bodies
  • 5.1.3. Opportunities
    • 5.1.3.1. Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
    • 5.1.3.2. Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
    • 5.1.3.3. Partnerships between hospitals and research institutions for innovative bilirubin test solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
    • 5.1.4.2. Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bilirubin Blood Test Market, by Test Type

• 6.1. Introduction
• 6.2. Delta Bilirubin Test
• 6.3. Direct Bilirubin (DBIL) Test
• 6.4. Indirect Bilirubin (IBIL) Test
• 6.5. Total Serum Bilirubin (TSB) Test
  • 6.5.1. Direct (Conjugated) Bilirubin Test
  • 6.5.2. Indirect (Unconjugated) Bilirubin Test

7. Bilirubin Blood Test Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers (ASCs)
• 7.3. Diagnostic Laboratories
• 7.4. Home Care Settings
• 7.5. Hospitals
• 7.6. Research Institutes

8. Bilirubin Blood Test Market, by Application

• 8.1. Introduction
• 8.2. Bile Duct Obstruction
• 8.3. Drug-Related Toxicity
• 8.4. Hemolytic Anemia
• 8.5. Liver Diseases
• 8.6. Newborn Jaundice

9. Bilirubin Blood Test Market, by Product

• 9.1. Introduction
• 9.2. Instruments
• 9.3. Reagents & Kits

10. Americas Bilirubin Blood Test Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Bilirubin Blood Test Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Bilirubin Blood Test Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies
• 3. Beckman Coulter
• 4. Bio-Rad Laboratories
• 5. DiaSorin
• 6. Fujifilm Holdings Corporation
• 7. GE Healthcare
• 8. Horiba Medical
• 9. Mindray
• 10. PerkinElmer
• 11. Philips Healthcare
• 12. Quidel Corporation
• 13. Randox Laboratories
• 14. Roche Diagnostics
• 15. Siemens Healthineers
• 16. Sysmex Corporation
• 17. Thermo Fisher Scientific
• 18. Tosoh Bioscience
• 19. Trinity Biotech